You've seen the tubs, the pre-workout labels and the "ultimate performance stack" bundles. Creatine plus beta-alanine is sold as a package deal, as if one amplifies the other. A new systematic review and network meta-analysis in the Journal of the International Society of Sports Nutrition tested that idea and found that creatine did the heavy lifting, and the combo added nothing measurable on top.
What the researchers actually did
Bai and Xu, from Jiangxi University of Science and Technology in China, followed PRISMA guidelines. They searched PubMed, Scopus and Web of Science through August 2025. They included randomized controlled trials of creatine, beta-alanine, or both together, lasting at least two weeks, in healthy adult athletes.
Fifty-two RCTs, all scoring 6 or higher on the PEDro quality scale, made the cut. A network meta-analysis lets researchers compare several interventions at once, including ones never tested head-to-head. Here that meant creatine alone, beta-alanine alone, the combination and placebo. Outcomes were sprint, jump, agility, upper- and lower-body muscular endurance, and repeated-sprint ability (RSA).
The headline: creatine delivered, the stack didn't
Compared with placebo, creatine alone significantly improved:
- Sprint performance: SMD = -0.64 (p = 0.04). The negative sign reflects faster times.
- Jump performance: SMD = 0.33 (p = 0.002)
- Repeated-sprint ability: SMD = -0.78 (p = 0.01)
- Upper-body muscular endurance: SMD = 0.43 (p = 0.01)
Creatine's P scores, the network meta-analysis ranking metric, were 0.90 or higher across these domains. That means it ranked at or near the top among the options.
Beta-alanine produced "non-significant or context-specific effects." The combination showed no synergistic benefits. The authors concluded that co-supplementation offers no additional advantage over creatine alone.
Why the "two pathways" logic didn't pan out
The stack makes sense on paper. Creatine supports phosphocreatine resynthesis and rapid ATP turnover. Beta-alanine raises muscle carnosine, which helps buffer acid. Different mechanisms suggest additive benefits.
The pooled data didn't show that. The authors say beta-alanine's buffering advantage appears task-specific and not enough to boost creatine's effect. In their reading, creatine's consistency comes from better phosphocreatine recovery and neuromuscular output, which matter for sprints, jumps and repeated efforts.
What didn't move
Creatine didn't significantly change agility or lower-body muscular endurance (both p > 0.05). Creatine isn't a cure-all, and the data don't support expecting gains in every performance test.
How solid is this evidence?
The paper has strengths. It includes only randomized trials with PEDro scores of 6 or higher, and the authors report no global inconsistency and no substantive publication bias.
There are also limitations to weigh:
- Heterogeneity varied. I² ranged from 0% to 73%, so some outcomes came from fairly inconsistent trials.
- Population: The review covers healthy adult athletes. The findings may not carry over to older adults, clinical populations or untrained beginners.
- Sex and sport differences: The authors call for more work on sex- and sport-specific responses, so average effects may hide subgroup differences.
- Duration and design: They ask for standardized, long-term, multi-arm RCTs to clarify possible interactions. The current evidence isn't the final word on whether any synergy exists.
- Beta-alanine isn't "useless." The finding is that it was non-significant or context-specific in this analysis and didn't augment creatine.
- Abstract-level detail: The abstract doesn't give total participant numbers or per-arm trial counts, so check the full paper before drawing finer conclusions.
Practical takeaways
Dose and timing: The abstract doesn't report dosing or timing protocols, so this paper can't tell you how much to take or when. Outside this study, the common approach in the wider literature is daily creatine monohydrate at about 3 to 5 grams, taken consistently. The analysis required at least two weeks of supplementation, so give it time before judging.
Who it's for: Based on these results, creatine suits athletes whose performance depends on sprinting, jumping, repeated high-intensity efforts or upper-body muscular endurance. Examples include team-sport players, sprinters and lifters.
Who might skip the stack: If your main goal is the extra boost from "stacking," this analysis gives you little reason to pay for the combo. If you already take beta-alanine and like it, nothing here proves it's harmful. The point is that it didn't enhance creatine's effect in this pooled data.
Who should be cautious: The review covers healthy adult athletes. Anyone with a medical condition, especially kidney issues, or who is pregnant or on medication should talk to a clinician before starting any supplement. That advice is general, not a finding from this paper.
Bottom line
If you're deciding where to put your supplement budget, this network meta-analysis of 52 RCTs backs creatine as the consistent performer for high-intensity and anaerobic work. Beta-alanine may help in specific contexts, but it didn't turn creatine into a better version of itself. Longer, better-designed multi-arm trials may refine the picture, but for now the stack hasn't earned its premium.